Hit-to-lead studies: the discovery of potent, orally active, thiophenecarboxamide IKK-2 inhibitors (Q40559431)

From Wikidata
Jump to navigation Jump to search
scientific article published on June 2004
edit
Language Label Description Also known as
English
Hit-to-lead studies: the discovery of potent, orally active, thiophenecarboxamide IKK-2 inhibitors
scientific article published on June 2004

    Statements

    Hit-to-lead studies: the discovery of potent, orally active, thiophenecarboxamide IKK-2 inhibitors (English)
    Andrew Baxter
    Steve Brough
    Anne Cooper
    Eike Floettmann
    Steve Foster
    Christine Harding
    Jason Kettle
    Tom McInally
    Craig Martin
    Michelle Mobbs
    Maurice Needham
    Pete Newham
    Stuart Paine
    Steve St-Gallay
    Sylvia Salter
    Yafeng Xue
    1 June 2004
    2817-2822

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit